Curative value of underwater endoscopic mucosal resection for submucosally invasive colorectal cancer. Issue 9 (11th April 2021)

• Record Type: Journal Article
• Authors: Fukuda, Hiromu; Takeuchi, Yoji; Shoji, Ayaka; Miyake, Muneaki; Matsueda, Katsunori; Inoue, Takahiro; Waki, Kotaro; Shimamoto, Yusaku; Kono, Mitsuhiro; Iwagami, Hiroyoshi; Nakahira, Hiroko; Matsuura, Noriko; Shichijo, Satoki; Maekawa, Akira; Kanesaka, Takashi; Yamamoto, Sachiko; Higashino, Koji; Uedo, Noriya; Ishihara, Ryu
• Is Part Of: Journal of gastroenterology and hepatology. Volume 36:Issue 9(2021)
• Page Start: 2471
• Page End: 2478
• Publication Date: 2021-04-11
• Subjects: Colorectal cancer -- Submucosal invasive cancer -- Underwater endoscopic mucosal resection; Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Liver Diseases -- Periodicals; 616.33
• DOI: 10.1111/jgh.15513
• Languages: English
• ISSNs: 0815-9319

Abstract

Abstract: Background and Aim: Occasionally, colorectal tumors without characteristics of deep submucosal invasion are found to be invasive upon pathological evaluation after endoscopic resection (ER). Because the resection depth for underwater endoscopic mucosal resection (UEMR) has not been clarified, we evaluated the feasibility of UEMR for pathologically invasive colorectal cancer (pT1‐CRC). Methods: We retrospectively investigated data on the backgrounds and outcomes of patients with pT1‐CRC who underwent UEMR between January 2014 and June 2019 at our institute. As a reference standard, the backgrounds and outcomes of pT1‐CRCs that had undergone conventional EMR (CEMR) were also investigated. Results: Thirty‐one patients (median age, 68 years [range, 32–88 years]; 22 men [71%]) were treated with UEMR. Median lesion size was 17 mm (range, 6–50 mm). The endoscopic complete resection rate was 100%. The overall en bloc resection rate was 77%, and the VM0, HM0, and R0 resection rates were 81%, 58%, and 55%, respectively. In cases of pT1a (invasion <1000 μm)‐CRC ( n = 14), the en bloc, VM0, and R0 resection rates were 92%, 100%, and 71%, respectively. Seventeen patients (five with risk factors for lymph node metastasis and 12 without) were followed up, and no local recurrence and distant metastasis were observed during the follow‐up period (median follow‐up period, 18 months [range, 6–62 months]) after UEMR. The outcomes of UEMR seemed to be comparable with those of CEMR ( n = 32). Conclusions: The VM0 rate of UEMR for pT1‐CRC, especially for pT1a‐CRC, without characteristics of deep submucosal invasion seems feasible.